Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Adlai Nortye Says It Has Completed Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) In Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC

Author: Benzinga Newsdesk | November 17, 2023 08:40am

Posted In: ANL